BioCentury
ARTICLE | Finance

IPO filing reveals details of Sana’s deep pipeline, aggregation of next-generation gene and cell therapy technologies

Sana proposes to raise $150M IPO, lifts the lid on technology suite and pipeline

January 13, 2021 9:58 PM UTC

With its IPO filing Wednesday, well-funded start-up Sana has lifted the lid on a suite of technologies it has aggregated since 2018, giving it a pipeline of 11 cell and gene therapies. Its first INDs could be filed as soon as 2022. 

Backed by an investor syndicate led by Arch Venture Partners and Flagship Pioneering, Seattle-based Sana Biotechnology Inc. proposed to raise up to $150 million, although the figure could be substantially higher once it prices the offering...

BCIQ Company Profiles

Sana Biotechnology Inc.